UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose

Drug and alcohol dependence, 2016-06, Vol.163, p.40-47

2016

Volltextzugriff (PDF)

Editorial: Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era

Frontiers in psychiatry, 2024-07, Vol.15, p.1443304

2024

Volltextzugriff (PDF)

Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework

Neurobiology of stress, 2018-11, Vol.9, p.84-104

Greenwald, Mark K.

2018

Volltextzugriff (PDF)

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder

Frontiers in pharmacology, 2022-11, Vol.13, p.1052113-1052113

2022

Volltextzugriff (PDF)

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

Frontiers in psychiatry, 2023-01, Vol.14, p.1103739-1103739

2023

Volltextzugriff (PDF)

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder

Drug and alcohol dependence reports, 2023-03, Vol.6, p.100133-100133, Article 100133

2023

Volltextzugriff (PDF)

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder

Harm reduction journal, 2023-12, Vol.20 (1), p.1-13, Article 173

2023

Volltextzugriff (PDF)

Effects of neuromodulation on cognitive and emotional responses to psychosocial stressors in healthy humans

Neurobiology of stress, 2023-01, Vol.22, p.100515-100515, Article 100515

2023

Volltextzugriff (PDF)

Gender-Specific Predictors of Retention and Opioid Abstinence During Methadone Maintenance Treatment

Journal of substance abuse treatment, 2015-07, Vol.54, p.37-43

2015

Volltextzugriff (PDF)

Perceptions of structural and provider-based substance use stigma interventions among primary care professionals

Drug and alcohol dependence reports, 2024-09, Vol.12, p.100259, Article 100259

2024

Volltextzugriff (PDF)

A randomized, sham-controlled, quintuple-blinded trial to evaluate the NET device as an alternative to medication for promoting opioid abstinence

Contemporary clinical trials communications, 2022-12, Vol.30, p.101018-101018, Article 101018

2022

Volltextzugriff (PDF)

Prevalence and predictors of peripheral neuropathy after breast cancer treatment

Cancer medicine (Malden, MA), 2021-10, Vol.10 (19), p.6666-6676

2021

Volltextzugriff (PDF)

Training medical students in opioid overdose prevention and response: Comparison of In-Person versus online formats

Medical education online, 2021-01, Vol.26 (1), p.1994906-1994906

2021

Volltextzugriff (PDF)

Behavioral Economic Factors Related to Pediatric Obesity

The Pediatric clinics of North America, 2016-06, Vol.63 (3), p.425-446

2016

Volltextzugriff (PDF)

Mediational pathways among drug use initiation, use-related consequences, and quit attempts

Drug and alcohol dependence reports, 2024-06, Vol.11, p.100229-100229, Article 100229

2024

Volltextzugriff (PDF)

Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes

Cancer medicine (Malden, MA), 2021-11, Vol.10 (22), p.8151-8161

2021

Volltextzugriff (PDF)

HIV chronicity as a predictor of hippocampal memory deficits in daily cannabis users living with HIV

Drug and alcohol dependence reports, 2023-12, Vol.9, p.100189-100189, Article 100189

2023

Volltextzugriff (PDF)

Buprenorphine maintenance and mu -opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy

Drug and alcohol dependence, 2014-11, Vol.144, p.1-11

2014

Volltextzugriff (PDF)

Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues

Neurotherapeutics, 2021-10, Vol.18 (4), p.2384-2396

2021

Volltextzugriff (PDF)

Effects of cocaine and/or heroin use on resting cardiovascular function

International journal of cardiology. Cardiovascular risk and prevention, 2021-12, Vol.11, p.200123-200123, Article 200123

2021

Volltextzugriff (PDF)

Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program

Substance abuse : research and treatment, 2022-01, Vol.16, p.11782218221138335-11782218221138335

2022

Volltextzugriff (PDF)

A Neuropharmacological Model to Explain Buprenorphine Induction Challenges

Annals of emergency medicine, 2022-12, Vol.80 (6), p.509-524

2022

Volltextzugriff (PDF)

Relationship between opioid cross-tolerance during buprenorphine stabilization and return to opioid use during buprenorphine dose tapering

Psychopharmacology, 2024-06, Vol.241 (6), p.1151-1160

2024

Volltextzugriff (PDF)

β‐Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use

The American journal on addictions, 2021-07, Vol.30 (4), p.351-357

2021

Volltextzugriff (PDF)

A Novel Online Curriculum and Coaching Strategy to Expand the Addiction Medicine Workforce: The Michigan Collaborative Addiction Resources and Education System

Academic medicine, 2022-02, Vol.97 (2), p.210-214

2022

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(214)
Mit Volltextzugriff
(199)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose

Editorial: Discovery, development and implementation of improved options for treating opioid overdose in the synthetic opioid era

Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder

Effects of neuromodulation on cognitive and emotional responses to psychosocial stressors in healthy humans

Gender-Specific Predictors of Retention and Opioid Abstinence During Methadone Maintenance Treatment

Perceptions of structural and provider-based substance use stigma interventions among primary care professionals

A randomized, sham-controlled, quintuple-blinded trial to evaluate the NET device as an alternative to medication for promoting opioid abstinence

Prevalence and predictors of peripheral neuropathy after breast cancer treatment

Training medical students in opioid overdose prevention and response: Comparison of In-Person versus online formats

Behavioral Economic Factors Related to Pediatric Obesity

Mediational pathways among drug use initiation, use-related consequences, and quit attempts

Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes

HIV chronicity as a predictor of hippocampal memory deficits in daily cannabis users living with HIV

Buprenorphine maintenance and mu -opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy

Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues

Effects of cocaine and/or heroin use on resting cardiovascular function

Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program

A Neuropharmacological Model to Explain Buprenorphine Induction Challenges

Relationship between opioid cross-tolerance during buprenorphine stabilization and return to opioid use during buprenorphine dose tapering

β‐Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use

A Novel Online Curriculum and Coaching Strategy to Expand the Addiction Medicine Workforce: The Michigan Collaborative Addiction Resources and Education System

Suchergebnisse filtern